Erythropoietin receptor binding antibodies
US7396913B2 · kind B2 · utility
7Cited by
8References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2003 |
| Grant date | Jul 8, 2008 |
| Priority date | — |
| Expiry date | Oct 20, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies and antibody fragments thereof that bind to and activate an erythropoietin receptor. The present invention also relates to methods of modulating the endogenous activity of an erythropoietin receptor in a mammal using said antibodies as well as pharmaceutical compositions containing said antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.